Kwan Y. Hui

967 total citations
23 papers, 803 citations indexed

About

Kwan Y. Hui is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kwan Y. Hui has authored 23 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Kwan Y. Hui's work include Receptor Mechanisms and Signaling (4 papers), HIV/AIDS drug development and treatment (4 papers) and HIV Research and Treatment (3 papers). Kwan Y. Hui is often cited by papers focused on Receptor Mechanisms and Signaling (4 papers), HIV/AIDS drug development and treatment (4 papers) and HIV Research and Treatment (3 papers). Kwan Y. Hui collaborates with scholars based in United States, Switzerland and Hong Kong. Kwan Y. Hui's co-authors include Edgar Haber, Gary R. Matsueda, Joseph A. Jakubowski, Christoph Bode, Eddie L. Angleton, Virginia L. Wyss, Edda F. Roberts, Barbara G. Utterback, Paul A. Hyslop and Ruth M. Kramer and has published in prestigious journals such as Science, Journal of Biological Chemistry and Circulation.

In The Last Decade

Kwan Y. Hui

23 papers receiving 764 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kwan Y. Hui United States 13 300 259 153 140 115 23 803
Andrew D. Westmuckett United States 14 355 1.2× 309 1.2× 98 0.6× 65 0.5× 129 1.1× 18 886
W Kisiel United States 12 332 1.1× 628 2.4× 187 1.2× 126 0.9× 57 0.5× 14 1.0k
Philip H. Johnson United Kingdom 16 485 1.6× 178 0.7× 49 0.3× 132 0.9× 56 0.5× 33 948
Robert J. Baugh United States 8 391 1.3× 425 1.6× 402 2.6× 161 1.1× 41 0.4× 9 1.1k
L. Morasca Italy 17 372 1.2× 101 0.4× 111 0.7× 106 0.8× 61 0.5× 63 850
John D. Kulman United States 16 276 0.9× 481 1.9× 34 0.2× 80 0.6× 91 0.8× 27 1.0k
P. Linssen Netherlands 18 540 1.8× 221 0.9× 128 0.8× 36 0.3× 83 0.7× 41 1.0k
M. Satya Murthy United States 16 273 0.9× 45 0.2× 83 0.5× 104 0.7× 73 0.6× 36 726
Naoki Watanabe Japan 21 527 1.8× 152 0.6× 124 0.8× 103 0.7× 17 0.1× 72 1.2k
Marion E. Schiphorst Netherlands 14 207 0.7× 844 3.3× 32 0.2× 206 1.5× 142 1.2× 20 1.3k

Countries citing papers authored by Kwan Y. Hui

Since Specialization
Citations

This map shows the geographic impact of Kwan Y. Hui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kwan Y. Hui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kwan Y. Hui more than expected).

Fields of papers citing papers by Kwan Y. Hui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kwan Y. Hui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kwan Y. Hui. The network helps show where Kwan Y. Hui may publish in the future.

Co-authorship network of co-authors of Kwan Y. Hui

This figure shows the co-authorship network connecting the top 25 collaborators of Kwan Y. Hui. A scholar is included among the top collaborators of Kwan Y. Hui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kwan Y. Hui. Kwan Y. Hui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuo, Ming‐Shang, John M. Kalbfleisch, Pamela Rutherford, et al.. (2008). Chemical analysis of atherosclerotic plaque cholesterol combined with histology of the same tissue. Journal of Lipid Research. 49(6). 1353–1363. 15 indexed citations
2.
Rekhter, Mark D., Kirk A. Staschke, Thomas Estridge, et al.. (2008). Genetic ablation of IRAK4 kinase activity inhibits vascular lesion formation. Biochemical and Biophysical Research Communications. 367(3). 642–648. 35 indexed citations
3.
Li, Wei‐Ming, Weiqun Shen, Robert M. Gill, et al.. (2006). High-Resolution Quantitative Computed Tomography Demonstrating Selective Enhancement of Medium-Size Collaterals by Placental Growth Factor-1 in the Mouse Ischemic Hindlimb. Circulation. 113(20). 2445–2453. 31 indexed citations
4.
Kervinen, Jukka, J. Łubkowski, Alexander Zdanov, et al.. (1998). Toward a universal inhibitor of retroviral proteases: Comparative analysis of the interactions of LP‐130 complexed with proteases from HIV‐1, FIV, and EIAV. Protein Science. 7(11). 2314–2323. 25 indexed citations
5.
Wlodawer, Alexander, Alla Gustchina, L. Reshetnikova, et al.. (1995). Structure of an inhibitor complex of the proteinase from feline immunodeficiency virus. Nature Structural & Molecular Biology. 2(6). 480–488. 55 indexed citations
6.
7.
Hui, Kwan Y., et al.. (1993). Model peptides to study the effects of P2 and P3 substitutions in statine‐containing HIV proteinase inhibitors. FEBS Letters. 327(3). 355–360. 8 indexed citations
8.
Hui, Kwan Y., Joseph A. Jakubowski, Virginia L. Wyss, & Eddie L. Angleton. (1992). Minimal sequence requirement of thrombin receptor agonist peptide. Biochemical and Biophysical Research Communications. 184(2). 790–796. 79 indexed citations
9.
Nussberger, Jürg, et al.. (1991). Angiotensin I and II disappear completely from circulating blood within 48 hours after binephrectomy. Journal of Hypertension. 9. S232–S232. 1 indexed citations
10.
Dubin, Daniel B., Richard E. Pratt, Kwan Y. Hui, & Victor J. Dzau. (1991). Characterization of prorenin activation using a synthetic peptide substrate. Journal of Hypertension. 9(6). 483–486. 2 indexed citations
11.
Nussberger, Juerg, et al.. (1991). Angiotensin I and II disappear completely from circulating blood within 48 hours after binephrectomy. Journal of Hypertension. 9(6). S232–S232. 5 indexed citations
12.
Hui, Kwan Y., et al.. (1989). Serine andd‐serine position‐1 substituted angiotensin II analogues Synthesis using new 2,3,5,6‐tetrafluorophenyl active esters and biological activities. International journal of peptide & protein research. 34(3). 177–183. 3 indexed citations
13.
Hui, Kwan Y., et al.. (1988). Design of rat renin inhibitory peptides. Journal of Medicinal Chemistry. 31(9). 1679–1686. 22 indexed citations
14.
Hui, Kwan Y., et al.. (1988). Protected amino acid tetrafluorophenyl esters for peptide synthesis. International journal of peptide & protein research. 31(2). 205–211. 8 indexed citations
15.
Haber, Edgar, Kwan Y. Hui, William D. Carlson, & Michael S. Bernatowicz. (1987). Renin Inhibitors. Journal of Cardiovascular Pharmacology. 10. 54–58. 7 indexed citations
16.
Hui, Kwan Y., William D. Carlson, Michael S. Bernatowicz, & Edgar Haber. (1987). Analysis of structure-activity relationships in renin substrate analog inhibitory peptides. Journal of Medicinal Chemistry. 30(8). 1287–1295. 16 indexed citations
18.
Bode, Christoph, Gary R. Matsueda, Kwan Y. Hui, & Edgar Haber. (1985). Antibody-Directed Urokinase: A Specific Fibrinolytic Agent. Science. 229(4715). 765–767. 122 indexed citations
19.
Hui, Kwan Y., Edgar Haber, & Gary R. Matsueda. (1985). Immunodetection of Human Fibrin Using Monoclonal Antibody-64C5 in an Extracorporeal Chicken Model. Thrombosis and Haemostasis. 54(2). 524–527. 16 indexed citations
20.
Hui, Kwan Y., Edgar Haber, & Gary R. Matsueda. (1983). Monoclonal Antibodies to a Synthetic Fibrin-Like Peptide Bind to Human Fibrin But Not Fibrinogen. Science. 222(4628). 1129–1132. 212 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026